Valuation: Biogen Inc.

Market Cap 31B 26.77B 25.14B 22.89B 43.01B 2,964B 43.63B 295B 115B 1,485B 116B 114B 4,942B P/E 2026 *
37.3x
P/E 2027 * 18.4x
Enterprise Value 35.94B 31.04B 29.14B 26.53B 49.86B 3,436B 50.58B 342B 134B 1,722B 135B 132B 5,729B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.14x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week+0.58%
Current month+3.05%
1 month+0.11%
3 months+8.40%
6 months+6.43%
Current year+18.84%
1 week 201
Extreme 201
215.6
1 month 196.92
Extreme 196.915
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 131.52
Extreme 131.52
219.72
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 27/10/2024
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Sell

Director

-593 0.0004%
09/06/26 Free

Director

1,505 0.0010%
13/02/26 Free

Head of Human Resources

8,025 0.0055%
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+0.58%+50.90%-21.15% 31B
+0.30%+2.75%+38.86%+1.08% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-3.45%+11.90%+164.29% 46.87B
-1.39%+1.82%-50.22%-50.44% 46.34B
+1.80%+8.94%+130.05%-34.84% 25.28B
+2.78%+2.44%+42.08%+90.79% 24.36B
+1.65%+0.53%-2.21%+190.26% 20.81B
+3.95%+1.02%+67.20%+117.59% 16.08B
+0.04%-5.43%+55.67%+168.09% 15.61B
Average +0.77%-0.23%+34.17%+65.46% 35.72B
Weighted average by Cap. +0.39%+0.27%+25.23%+44.96%

Financials

2026 *2027 *
Net sales 10.44B 9.02B 8.47B 7.71B 14.49B 998B 14.7B 99.3B 38.86B 500B 39.2B 38.35B 1,665B 10.66B 9.21B 8.64B 7.87B 14.79B 1,019B 15B 101B 39.67B 511B 40.02B 39.15B 1,699B
Net income 953M 823M 773M 704M 1.32B 91.11B 1.34B 9.06B 3.55B 45.65B 3.58B 3.5B 152B 1.9B 1.64B 1.54B 1.4B 2.63B 182B 2.67B 18.06B 7.07B 90.98B 7.13B 6.98B 303B
Net Debt 4.94B 4.26B 4B 3.64B 6.85B 472B 6.95B 46.94B 18.37B 236B 18.53B 18.13B 787B 2.42B 2.09B 1.96B 1.79B 3.36B 231B 3.41B 23.01B 9.01B 116B 9.09B 8.89B 386B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
17/08/26 US$209.15 -0.32% 617,087
14/08/26 US$209.83 -0.39% 554,816
13/08/26 US$210.65 +0.85% 860,094
12/08/26 US$208.87 +2.44% 789,441
11/08/26 US$203.89 -1.56% 936,834
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
209.83USD
Average target price
235.57USD
Spread / Average Target
+12.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock